Namescystospaz
Namescystospaz Uses, Dosage, Side Effects, Food Interaction and all others data.
Namescystospaz is a tropane alkaloid and the levo-isomer of atropine. It is commonly extracted from plants in the Solanaceae or nightshade family. Research into the action of hyoscyamine in published literature dates back to 1826. Namescystospaz is used for a wide variety of treatments and therapeutics due to its antimuscarinic properties.
Although hyoscyamine is marketed in the United States, it is not FDA approved.
Namescystospaz is not FDA approved, and so it has not official indications. However, it is used as an antimuscarinic agent in a number of treatments and therapies. Namescystospaz has a short duration of action as it may need to be given multiple times per day. Patients should be counselled regarding the risks and signs of anticholinergic toxicity.
Trade Name | Namescystospaz |
Availability | Prescription only |
Generic | Hyoscyamine |
Hyoscyamine Other Names | (S)-atropine, Daturin, Daturine, Duboisine, Hyoscyamin, Hyoscyamine, Hyoscyaminum, L-Hyoscyamine, L-Tropine tropate, Tropine-L-tropate |
Related Drugs | diazepam, fentanyl, dicyclomine, oxybutynin, lidocaine, Valium, Bentyl, simethicone, ketamine, propofol |
Weight | 0.125mg/5ml, 0.125mg/ml, 0.125mg, 0.125mg, 0.375mg, 0.375mgdual + release, 0.125mg |
Type | Oral liquid, oral solution, oral tablet, oral tablet, disintegrating, oral tablet, extended release, sublingual tablet |
Formula | C17H23NO3 |
Weight | Average: 289.3694 Monoisotopic: 289.167793607 |
Groups | Approved |
Therapeutic Class | |
Manufacturer | |
Available Country | United States |
Last Updated: | September 19, 2023 at 7:00 am |
![Namescystospaz Namescystospaz](https://www.medicinesfaq.com/media/png/namescystospaz.png)
Uses
Namescystospaz is an anticholinergic indicated to treat functional gastrointestinal disorders, biliary and renal colic, and acute rhinitis.
As a drug that is not FDA approved, hyscyamine has no official indications. Intravenous hysocyamine has been used to reduce gastric motility, reduce pancreatic pain and secretions, to facilitate imaging of the gastrointestinal tract, treat anticholinesterase toxicity, treat certain cases of partial heart block, improve visualization of the kidneys, and for symptomatic relief of biliary and renal colic. Intravenous hyoscyamine is also used pre-operatively to reduce secretions of the mouth and respiratory tract to facilitate intubation. Oral hyoscyamine is used to treat functional intestinal disorders, for symptomatic relief of biliary and renal colic, and symptomatic relief of acute rhinitis.
Namescystospaz is also used to associated treatment for these conditions: Biliary Colic, Colic, Cystitis, Diverticulitis, Heart Block, Irritable Bowel Syndrome (IBS), Neurogenic Bladder Dysfunction, Neurogenic Bowel Dysfunction, Pancreatitis, Parkinsonism, Peptic Ulcer, Poisoning caused by anticholinesterases, Pylorospasm, Renal Colic, Spastic bladder, Tracheo-bronchial secretion excess, Acute Enterocolitis, Acute Rhinitis, Gastric secretions, Mild Dysentery, Pharyngeal secretions, Salivary secretions, Spastic colitis
How Namescystospaz works
Namescystospaz competitively and non-selectively antagonises muscarinic receptors in the smooth muscle, cardiac muscle, sino-atrial node, atrioventricular node, exocrine nodes, gastrointestinal tract, and respiratory tract. Antagonism of muscarinic M1, M4, and M5 receptors in the central nervous system lead to cognitive impairment; antagonism of M2 in the sinoatrial and atrioventricular nodes leads to bradycardia and lowers contractility; and antagonism of M3 in smooth muscle results in reduced peristalsis, bladder contraction, salivary secretions, gastric secretions, bronchial secretions, sweating, increased bronchodilation, mydriasis, and cycloplegia.
Toxicity
Patients experiencing an overdose may present with headache, nausea, vomiting, dizziness, dry mouth, difficulty in swallowing, dilated pupils, blurred vision, urinary retention, hot dry and flushed skin, tachycardia, hypertension, hypotension, respiratory depression, CNS stimulation, fever, ataxia, excitation, lethargy, stupor, coma, and paralysis. Patients should be treated with symptomatic and supportive therapy which may include emesis, gastric lavage, activated charcoal, artificial respiration, or intravenous physostigmine. Dialysis is expected to remove hyoscyamine sulfate from circulation.
Food Interaction
- Take before a meal. Take 30-60 minutes before a meal.
- Take separate from antacids. Take oral hyoscyamine before meals and antacids after meals.
Namescystospaz Alcohol interaction
[Moderate] GENERALLY AVOID:
Use of anticholinergic agents with alcohol may result in sufficient impairment of attention so as to render driving and operating machinery more hazardous.
In addition, the potential for abuse may be increased with the combination.
The mechanism of interaction is not established but may involve additive depressant effects on the central nervous system.
No effect of oral propantheline or atropine on blood alcohol levels was observed in healthy volunteers when administered before ingestion of a standard ethanol load.
However, one study found impairment of attention in subjects given atropine 0.5 mg or glycopyrrolate 1 mg in combination with alcohol.
Alcohol should generally be avoided during therapy with anticholinergic agents.
Patients should be counseled to avoid activities requiring mental alertness until they know how these agents affect them.
Namescystospaz Hypertension interaction
[Minor] Cardiovascular effects of anticholinergics may exacerbate hypertension.
Therapy with anticholinergic agents should be administered cautiously in patients with hypertension.
Namescystospaz Drug Interaction
Moderate: diphenhydramine, cyclobenzaprine, acetaminophen / hydrocodoneMinor: acetaminophenUnknown: duloxetine, omega-3 polyunsaturated fatty acids, fluticasone nasal, pregabalin, polyethylene glycol 3350, esomeprazole, albuterol, pantoprazole, montelukast, levothyroxine, cyanocobalamin, ascorbic acid, cholecalciferol, alprazolam, ondansetron, cetirizine
Namescystospaz Disease Interaction
Major: autonomic neuropathy, GI obstruction, glaucoma, obstructive uropathy, reactive airway diseases, myasthenia gravis, infectious diarrheaModerate: cardiac disease, tachycardia, coronary artery disease, gastric ulcer, gastroesophageal reflux, ulcerative colitis, liver disease, renal failureMinor: hypertension, hyperthyroidism, diarrhea, fever
Elimination Route
Namescystospaz is completely absorbed by sublingual and oral routes, though exact data regarding the Cmax, Tmax, and AUC are not readily available.
Half Life
The half life of hyoscyamine is 3.5 hours.
Elimination Route
The majority of hyoscyamine is eliminated in the urine as the unmetabolized parent compound.
Innovators Monograph
You find simplified version here Namescystospaz